BofA/Merrill Lynch Upgrades Onyx Pharmaceuticals (ONXX) to Buy
Tweet Send to a Friend
BofA/Merrill Lynch upgraded Onyx Pharmaceuticals (NASDAQ: ONXX) from Neutral to Buy and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE